Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Clinical trials on JAKi for treating patients with vitiligo according to clinicaltrials.gov.
|
Disease
type |
Inhibitor | Target | Administration | Phase | Study number |
|---|---|---|---|---|---|
| Vitiligo | Ruxolitinib | JAK1 JAK2 | Topical | Phase II | NCT03099304 |
| Ruxolitinib | JAK1 JAK2 | Topical | Phase II | NCT02809976 | |
| ATI-502 | JAK1 JAK3 | Topical | Phase II | NCT03468855 | |
| PF-06651600 PF-06700841 |
JAK3 JAK1 TYK2 |
Oral | Phase II | NCT03715829 |
